These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4212515)

  • 1. Viral vaccines: various cell substrates and long-term prospective studies.
    Kirschstein RL; Petricciani JC
    Adv Exp Med Biol; 1972; 31(0):197-206. PubMed ID: 4212515
    [No Abstract]   [Full Text] [Related]  

  • 2. Monitoring vaccines for human oncogenicity.
    Miller RW
    Natl Cancer Inst Monogr; 1968 Dec; 29():453-5. PubMed ID: 4305436
    [No Abstract]   [Full Text] [Related]  

  • 3. Preparation of vaccines--cell substrates.
    Perkins FT
    Adv Exp Med Biol; 1972; 31(0):187-96. PubMed ID: 4212264
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical experience with vaccines produced in the human diploid cell line WI-38.
    Andzaparidze OG
    Natl Cancer Inst Monogr; 1968 Dec; 29():477-84. PubMed ID: 4976367
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antigenicity of 4 antiviral vaccines].
    Ruiz-Gómez J
    Gac Med Mex; 1973 Jun; 105(6):599-608. PubMed ID: 4731998
    [No Abstract]   [Full Text] [Related]  

  • 6. Origin of endogenous and exogenous agents in cell cultures.
    Hopps HE
    In Vitro; 1974; 10(5-6):243-6. PubMed ID: 4217763
    [No Abstract]   [Full Text] [Related]  

  • 7. Impotency of live-virus vaccines as a result of improper handling in clinical practice.
    Krugman RD; Meyer BC; Enterline JC; Parkman PD; Witte JJ; Meyer HM
    J Pediatr; 1974 Oct; 85(4):512-4. PubMed ID: 4443859
    [No Abstract]   [Full Text] [Related]  

  • 8. Virologic control of monkeys used for the production of poliomyelitis virus vaccine.
    Osterhaus AD; van Steenis G
    Dev Biol Stand; 1981; 47():157-61. PubMed ID: 6785124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory testing in rubella vaccine control.
    Hopps HE; Parkman PD; Meyer HM
    Am J Dis Child; 1969 Aug; 118(2):338-45. PubMed ID: 4978512
    [No Abstract]   [Full Text] [Related]  

  • 10. Tissue and medium antigens in vaccines.
    Coriell LL
    Natl Cancer Inst Monogr; 1968 Dec; 29():179-91. PubMed ID: 4976862
    [No Abstract]   [Full Text] [Related]  

  • 11. Bacteriophages and endotoxin in licensed live-virus vaccines.
    Moody EE; Trousdale MD; Jorgensen JH; Shelokov A
    J Infect Dis; 1975 May; 131(5):588-91. PubMed ID: 805187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of host-incorporated antigens in the immune response to measles virus.
    Isacson P
    Int Arch Allergy Appl Immunol; 1969; 36():Suppl:139-45. PubMed ID: 4313661
    [No Abstract]   [Full Text] [Related]  

  • 13. Proposals on the control of VERO cells used to prepare inactivated poliomyelitis vaccine.
    Ménetrat JL; Chaniot S; Lefrançois S; Canale A; Chippaux A
    Dev Biol Stand; 1981; 47():163-7. PubMed ID: 6785125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue and medium antigens in vaccines--discussion.
    Feldman HA
    Natl Cancer Inst Monogr; 1968 Dec; 29():193-4. PubMed ID: 5720791
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biology of attenuated mumps, rubella, measles and rabies viruses. Comparative considerations on the methods of attenuation of their virulence].
    Ciaccio G
    Riv Biol; 1970; 63(1):87-129. PubMed ID: 4996066
    [No Abstract]   [Full Text] [Related]  

  • 16. Characteristics of primary cultures and diploid cells--technology of production.
    Holper JC
    Natl Cancer Inst Monogr; 1968 Dec; 29():21-31. PubMed ID: 4976359
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of sensitizing tissue culture components in viral vaccines.
    Wilson S; Weber JC; Aprile MA; Macmorine HG
    J Allergy; 1968 Dec; 42(6):319-29. PubMed ID: 4973120
    [No Abstract]   [Full Text] [Related]  

  • 18. Animal cell strains as substitutes for primary monkey cultures in testing Salk and other inactivated vaccines for persistent viruses.
    Farrell LN
    Prog Immunobiol Stand; 1967; 3():27-33. PubMed ID: 4314429
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of animals in the development and control of viral vaccines.
    Minor PD
    Dev Biol Stand; 1996; 86():113-20. PubMed ID: 8785940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An attenuated rubella virus vaccine (Cendehill 51 strain) grown in primary rabbit kidney cells.
    Huygelen C; Peetermans J; Prinzie A
    Prog Med Virol; 1969; 11():107-25. PubMed ID: 4984707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.